BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Diagnosis
21 results:

  • 1. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
    Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
    Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prediction model of ocular metastasis from primary liver cancer: Machine learning-based development and interpretation study.
    Sun JQ; Wu SN; Mou ZL; Wen JY; Wei H; Zou J; Li QJ; Liu ZL; Xu SH; Kang M; Ling Q; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
    Cancer Med; 2023 Oct; 12(20):20482-20496. PubMed ID: 37795569
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical significance of cylindromatosis expression in primary hepatocellular carcinoma.
    Tang SY; Xu Y; Jiao CC; Jiang MH; Kong N; Ding H; Cui LH; Piao JM
    Arab J Gastroenterol; 2023 Feb; 24(1):58-64. PubMed ID: 36720665
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening.
    Kolb JM; Chen M; Tavakkoli A; Gallegos J; O'Hara J; Tarter W; Hochheimer CJ; Golubski B; Kopplin N; Hennessey L; Kalluri A; Devireddy S; Scott FI; Falk GW; Singal AG; Vajravelu RK; Wani S
    Am J Gastroenterol; 2023 Apr; 118(4):615-626. PubMed ID: 36219171
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
    Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
    Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Wang S; Zheng R; Arnold M; Abnet C; Zeng H; Zhang S; Chen R; Sun K; Li L; An L; Bray F; Wei W; He J
    Int J Cancer; 2022 Nov; 151(9):1447-1461. PubMed ID: 35678331
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
    Sawas T; Majzoub AM; Haddad J; Tielleman T; Nayfeh T; Yadlapati R; Singh S; Kolb J; Vajravelu RK; Katzka DA; Wani S;
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e31-e50. PubMed ID: 33901662
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Receipt of Serial Endoscopy Procedures Prior to Esophageal Adenocarcinoma diagnosis Is Associated with Better Survival.
    Cummings LC; Kou TD; Chak A; Schluchter MD; Margevicius S; Cooper GS
    Dig Dis Sci; 2022 Mar; 67(3):1036-1044. PubMed ID: 33881677
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Extrapulmonary small cell carcinoma of the external auditory canal: a case report and review of the literature.
    Wang J; Liu D; Meng Y; Guo Y; Zhao M
    J Int Med Res; 2020 Aug; 48(8):300060520946517. PubMed ID: 32851892
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Racial and ethnic disparities in mortality from gastric and esophageal adenocarcinoma.
    Laszkowska M; Tramontano AC; Kim J; Camargo MC; Neugut AI; Abrams JA; Hur C
    Cancer Med; 2020 Aug; 9(15):5678-5686. PubMed ID: 32573964
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
    Săftoiu A; Hassan C; Areia M; Bhutani MS; Bisschops R; Bories E; Cazacu IM; Dekker E; Deprez PH; Pereira SP; Senore C; Capocaccia R; Antonelli G; van Hooft J; Messmann H; Siersema PD; Dinis-Ribeiro M; Ponchon T
    Endoscopy; 2020 Apr; 52(4):293-304. PubMed ID: 32052404
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Radiofrequency Ablation in Patients with Barrett's Esophagus- related Neoplasia - Long-Term Outcomes in the Czech National Database.
    Krajciova J; Janicko M; Falt P; Gregar J; Suchanek S; Ngo O; Kollar M; Urban O; Prochazka V; Zavoral M; Spicak J; Martinek J
    J Gastrointestin Liver Dis; 2019 Jun; 28():149-155. PubMed ID: 31204400
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Barrett oesophagus.
    Peters Y; Al-Kaabi A; Shaheen NJ; Chak A; Blum A; Souza RF; Di Pietro M; Iyer PG; Pech O; Fitzgerald RC; Siersema PD
    Nat Rev Dis Primers; 2019 May; 5(1):35. PubMed ID: 31123267
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Accuracy of Pretransplant Imaging Diagnostic for Hepatocellular Carcinoma: A Retrospective German Multicenter Study.
    Herden U; Schoening W; Pratschke J; Manekeller S; Paul A; Linke R; Lorf T; Lehner F; Braun F; Stippel DL; Sucher R; Schmidt H; Strassburg CP; Guba M; van Rosmalen M; Rogiers X; Samuel U; Schön GM; Nashan B
    Can J Gastroenterol Hepatol; 2019; 2019():8747438. PubMed ID: 30949459
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Goldani F; Parizadeh SMR; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(11):1129-1140. PubMed ID: 30848198
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.
    Codipilly DC; Chandar AK; Singh S; Wani S; Shaheen NJ; Inadomi JM; Chak A; Iyer PG
    Gastroenterology; 2018 Jun; 154(8):2068-2086.e5. PubMed ID: 29458154
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis.
    Chu JN; Choi J; Tramontano A; Morse C; Forcione D; Nishioka NS; Abrams JA; Rubenstein JH; Kong CY; Inadomi JM; Hur C
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):392-400.e7. PubMed ID: 29079222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. FABP1 and Hepar expression levels in Barrett's esophagus and associated neoplasia in an Asian population.
    Srivastava S; Kern F; Sharma N; McKeon F; Xian W; Yeoh KG; Ho KY; Teh M
    Dig Liver Dis; 2017 Oct; 49(10):1104-1109. PubMed ID: 28807490
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Impact of a Prior diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.
    Tramontano AC; Sheehan DF; Yeh JM; Kong CY; Dowling EC; Rubenstein JH; Abrams JA; Inadomi JM; Schrag D; Hur C
    Am J Gastroenterol; 2017 Aug; 112(8):1256-1264. PubMed ID: 28374815
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Alpha-fetoprotein-producing esophageal adenocarcinoma: a mimicker of hepatocellular carcinoma.
    Wang J; Liu W; Parikh K; Post AB
    Clin J Gastroenterol; 2017 Feb; 10(1):7-12. PubMed ID: 27995468
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.